J&J creates new IoT architecture with TCS
4
MINS READ
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
LIFE SCIENCES/ ARTICLE
Jun Chen, Head - Supply Chain Digital Product Management, Johnson & Johnson, discusses how the company has been making strides toward its mission of creating a healthier world with TCS fueling digital transformation.
You have these already downloaded
We have sent you a copy of the report to your email again.
How TCS' IoT expertise enhanced J&J’s digital transformation journey
Johnson & Johnson (J&J), the world's largest pharmaceutical, medical devices, and consumer products healthcare company, endeavored to improve healthcare access and affordability, and create healthier communities.
Legacy systems and applications and vendor-dependencies were limiting J&J’s potential. They aimed to build a technology stack, improve the customer experience, and open new business opportunities, and chose TCS as their digital transformation partner.
With TCS' trust, innovation, and reliability, J&J aspired to keep customers’ health and well-being at the core of their vision. Using TCS' IoT expertise, J&J and TCS are designing new opensource IoT platforms that drive innovation and agility in the product development and supply chain processes, to deliver better quality products to patients and provide superior patient outcomes.
Combining the power of data, artificial intelligence (AI), and machine learning (ML), and moving from a vendor-specific solution to a self-serving solution, helped J&J reduce their release time from up to 35 days to two hours.
TCS’ deep contextual knowledge, digital strategy, and technology stack have enabled J&J to revolutionize their manufacturing process.
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Reimagining Pharma Labeling with New-Age Technologies
TCS Life Sciences Forum: Unlocking the Power of AI and Generative AI
EU MDR deadline extension: Making medtech manufacturers future-ready
Integrating Safety and Regulatory Functions -- A Bold Step in Pharma